ALNY logo

Alnylam Pharmaceuticals (ALNY) Total Assets

Annual Total Assets

$3.83 B
+$283.52 M+7.99%

31 December 2023

ALNY Total Assets Chart

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Quarterly Total Assets

$4.21 B
+$195.41 M+4.87%

30 September 2024

ALNY Quarterly Total Assets Chart

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

ALNY Total Assets Performance

PeriodPeriodAnnualAnnualQuarterlyQuarterly
1 y1 year+8.0%+9.5%
3 y3 years+12.4%+21.1%
5 y5 years+143.2%+65.5%

ALNY Total Assets High & Low

PeriodPeriodAnnual vs highAnnual vs highAnnual vs lowAnnual vs lowQuarter. vs highQuarter. vs highQuarter. vs lowQuarter. vs low
3 y3 yearsat high+12.4%at high+26.3%
5 y5 yearsat high+143.2%at high+84.5%
alltimeall timeat high>+9999.0%at high>+9999.0%

Alnylam Pharmaceuticals Total Assets History

DateAnnualQuarterly
Sept 2024
-
$4.21 B(+4.9%)
June 2024
-
$4.01 B(+4.8%)
Mar 2024
-
$3.82 B(-0.1%)
Dec 2023
$3.83 B(+8.0%)
$3.83 B(-0.2%)
Sept 2023
-
$3.84 B(+12.8%)
June 2023
-
$3.40 B(+0.3%)
Mar 2023
-
$3.39 B(-4.4%)
Dec 2022
$3.55 B(-2.7%)
$3.55 B(+0.3%)
Sept 2022
-
$3.54 B(+6.2%)
June 2022
-
$3.33 B(-3.0%)
Mar 2022
-
$3.43 B(-5.8%)
Dec 2021
$3.64 B(+6.9%)
$3.64 B(+4.9%)
Sept 2021
-
$3.47 B(-1.1%)
June 2021
-
$3.51 B(+7.8%)
Mar 2021
-
$3.26 B(-4.5%)
Dec 2020
$3.41 B(+42.2%)
$3.41 B(+3.0%)
Sept 2020
-
$3.31 B(-2.0%)
June 2020
-
$3.37 B(+48.0%)
Mar 2020
-
$2.28 B(-4.8%)
Dec 2019
$2.40 B(+52.1%)
$2.40 B(-5.8%)
Sept 2019
-
$2.54 B(-6.4%)
June 2019
-
$2.72 B(+34.9%)
Mar 2019
-
$2.01 B(+27.9%)
Dec 2018
$1.57 B(-21.1%)
$1.57 B(-6.0%)
Sept 2018
-
$1.68 B(-6.4%)
June 2018
-
$1.79 B(-7.0%)
Mar 2018
-
$1.92 B(-3.6%)
Dec 2017
$1.99 B(+58.0%)
$1.99 B(+46.9%)
Sept 2017
-
$1.36 B(-5.3%)
June 2017
-
$1.43 B(+26.5%)
Mar 2017
-
$1.13 B(-10.2%)
Dec 2016
$1.26 B(-8.9%)
$1.26 B(-3.8%)
Sept 2016
-
$1.31 B(-5.0%)
June 2016
-
$1.38 B(+5.0%)
Mar 2016
-
$1.32 B(-5.0%)
Dec 2015
$1.39 B(+28.4%)
$1.39 B(-3.5%)
Sept 2015
-
$1.44 B(-6.2%)
June 2015
-
$1.53 B(-6.0%)
Mar 2015
-
$1.63 B(+50.9%)
Dec 2014
$1.08 B
$1.08 B(+9.5%)
Sept 2014
-
$986.36 M(-4.5%)
June 2014
-
$1.03 B(-4.4%)
DateAnnualQuarterly
Mar 2014
-
$1.08 B(+156.9%)
Dec 2013
$420.53 M(+46.3%)
$420.53 M(-6.0%)
Sept 2013
-
$447.50 M(-3.3%)
June 2013
-
$462.56 M(-1.9%)
Mar 2013
-
$471.58 M(+64.0%)
Dec 2012
$287.52 M(+2.0%)
$287.52 M(-10.8%)
Sept 2012
-
$322.35 M(+1.2%)
June 2012
-
$318.48 M(-6.4%)
Mar 2012
-
$340.30 M(+20.7%)
Dec 2011
$281.92 M(-28.3%)
$281.92 M(-9.1%)
Sept 2011
-
$310.22 M(-9.0%)
June 2011
-
$340.83 M(-7.6%)
Mar 2011
-
$369.05 M(-6.2%)
Dec 2010
$393.26 M(-18.3%)
$393.26 M(-4.7%)
Sept 2010
-
$412.61 M(-6.3%)
June 2010
-
$440.18 M(-5.0%)
Mar 2010
-
$463.41 M(-3.7%)
Dec 2009
$481.38 M(-13.2%)
$481.38 M(-2.9%)
Sept 2009
-
$495.67 M(-4.4%)
June 2009
-
$518.65 M(-6.5%)
Mar 2009
-
$554.53 M(-0.0%)
Dec 2008
$554.68 M(+12.3%)
$554.68 M(-4.4%)
Sept 2008
-
$580.18 M(+0.0%)
June 2008
-
$580.05 M(+19.3%)
Mar 2008
-
$486.26 M(-1.5%)
Dec 2007
$493.79 M(+105.7%)
$493.79 M(-2.2%)
Sept 2007
-
$505.09 M(+129.9%)
June 2007
-
$219.66 M(-3.4%)
Mar 2007
-
$227.34 M(-5.3%)
Dec 2006
$240.01 M(+144.0%)
$240.01 M(+66.1%)
Sept 2006
-
$144.53 M(-1.8%)
June 2006
-
$147.11 M(-4.3%)
Mar 2006
-
$153.69 M(+56.3%)
Dec 2005
$98.35 M(+48.8%)
$98.35 M(+127.4%)
Sept 2005
-
$43.25 M(-15.0%)
June 2005
-
$50.86 M(-13.9%)
Mar 2005
-
$59.07 M(-10.6%)
Dec 2004
$66.11 M(+87.9%)
$66.11 M(+5.7%)
Sept 2004
-
$62.55 M(-8.7%)
June 2004
-
$68.47 M(+74.1%)
Mar 2004
-
$39.34 M(+11.8%)
Dec 2003
$35.18 M(+118.4%)
$35.18 M
Dec 2002
$16.11 M
-

FAQ

  • What is Alnylam Pharmaceuticals annual total assets?
  • What is the all time high annual total assets for Alnylam Pharmaceuticals?
  • What is Alnylam Pharmaceuticals annual total assets year-on-year change?
  • What is Alnylam Pharmaceuticals quarterly total assets?
  • What is the all time high quarterly total assets for Alnylam Pharmaceuticals?
  • What is Alnylam Pharmaceuticals quarterly total assets year-on-year change?

What is Alnylam Pharmaceuticals annual total assets?

The current annual total assets of ALNY is $3.83 B

What is the all time high annual total assets for Alnylam Pharmaceuticals?

Alnylam Pharmaceuticals all-time high annual total assets is $3.83 B

What is Alnylam Pharmaceuticals annual total assets year-on-year change?

Over the past year, ALNY annual total assets has changed by +$283.52 M (+7.99%)

What is Alnylam Pharmaceuticals quarterly total assets?

The current quarterly total assets of ALNY is $4.21 B

What is the all time high quarterly total assets for Alnylam Pharmaceuticals?

Alnylam Pharmaceuticals all-time high quarterly total assets is $4.21 B

What is Alnylam Pharmaceuticals quarterly total assets year-on-year change?

Over the past year, ALNY quarterly total assets has changed by +$365.97 M (+9.53%)